Insights on the Global Fertility Medicines Market to 2021 | Industry Statistics, Emerging Demands, Forecast to 2027
The global fertility medicines market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The market growth is majorly attributed to the rising cases of infertility among males as well as females all over the globe. With the rapid rise of the working population and the adoption of a sedentary lifestyle, what has caught pace is the case of infertility all over the globe. As a result of this, the sales of fertility drugs and related services aimed at enhancing the production of sperms and eggs in order to promote fertility among men and women have grown substantially in the past few years. Fertility drugs are the first line of treatment for infertility that works by regulating and stimulating ovulation in women and increasing the sperm count in men.
To Request a Sample of our Report on Global Fertility
Medicines Market: https://www.omrglobal.com/request-sample/fertility-medicines-market
Further, substantial strategic activities are
undertaken by the market players that support the market growth. For instance,
in 2019, Ferring Pharmaceuticals, a US-based biopharmaceutical company,
acquired US commercialization rights of Ganirelix Acetate Injection from Sun
Pharmaceutical Industries Ltd. for an unrevealed amount. With this acquisition,
Ferring Pharmaceutical aimed to broaden its medicine portfolio targeted towards
reproduction. Ganirelix Acetate Injection was approved by FDA in 2018 and is
used to regulate premature luteinizing hormone (LH) levels in women undergoing
fertility treatment. Sun Pharmaceutical Industries Ltd is an India-based
manufacturer and seller of pharmaceutical formulations and active
pharmaceutical ingredients.
Some key players operating in the market include
Ferring Pharmaceutical, Merck, Abbott, Bayer AG, and others. These players are
eyeing on strengthening their position in the market by adopting various
strategies as mergers and acquisitions, partnerships, collaborations, new
product launch and development in the existing product portfolio, and so on.
Market Coverage
·
The market number available for – 2020-2027
·
Base year- 2020
·
Forecast period- 2021-2027
·
Segment Covered
·
Regions Covered- Globally
·
Competitive Landscape:
Abbott, Merck, Bayer AG, and Ferring Pharmaceuticals.
(Get 15% Discount on Buying this Report)
A
full Report of Global Fertility Medicines Market is Available at: https://www.omrglobal.com/industry-reports/fertility-medicines-market
Global Fertility Medicines Market - Segmentation
By Drugs
• Gonadotropin
• Anti-Estrogen
By End-User
• Male
• Female
Global Fertility Medicines Market Segmentation by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert research
analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment